ArticleAnnals of clinical and translational neurology2023

Intranasal neuropeptide Y1 receptor antagonism improves motor deficits in symptomatic SOD1 ALS mice.

Rosemary M Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.